VRPX

Virpax Pharmaceuticals, Inc. Common Stock
VRPX

Overview Fund Activity
Delisted

VRPX was delisted on the 3rd of April, 2025.

Back to rankings

7 hedge funds and large institutions have $34.9K invested in Virpax Pharmaceuticals, Inc. Common Stock in 2025 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 6 reducing their positions, and 6 closing their positions.

Holders
7
Holders Change
-5
Holders Change %
-41.67%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
6
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Millennium Management
1
Millennium Management
New York
$26.5K

Top Sellers

1
Geode Capital Management
1
Geode Capital Management
Massachusetts
$0
2
UBS Group
2
UBS Group
Switzerland
$2.4K
3
HF
3
HRT Financial
New York
$0
4
VF
4
Virtu Financial
New York
$0
5
XT
5
XTX Topco
Cayman Islands
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Millennium Management
1
Millennium Management
New York
$26.5K 22,075 +22,075 New
TRCT
2
Tower Research Capital (TRC)
New York
$5.88K 4,897 -2,857 -37%
UBS Group
3
UBS Group
Switzerland
$2.4K 2,000 -11,100 -85%
SS
4
SBI Securities
Japan
$130 108 -492 -82%
Osaic Holdings
5
Osaic Holdings
Arizona
$10 9 -231 -96%
Bank of America
6
Bank of America
North Carolina
$6 5 -60 -92%
VWM
7
Vermillion Wealth Management
Minnesota
$5 4 -96 -96%
Geode Capital Management
8
Geode Capital Management
Massachusetts
– – -41,899 Closed
HF
9
HRT Financial
New York
– – -25,368 Closed
VF
10
Virtu Financial
New York
– – -23,657 Closed
XT
11
XTX Topco
Cayman Islands
– – -12,905 Closed
Morgan Stanley
12
Morgan Stanley
New York
– – -499 Closed
HFS
13
Hantz Financial Services
Michigan
– – -10 Closed
CFGS
14
Concourse Financial Group Securities
Alabama
– – – –